Houston, Texas 77030


The goal of this study is to learn about the quality of life (QOL) in participants with advanced lung cancer.

Study summary:

Advanced lung cancer (ALC) will be assessed for participant outcomes in a sample which is prior initiation of palliative consultation and in a sample after the initiation of early palliative consultation. Study goals are: I. To determine the differences in participant outcomes including quality of life (QOL); symptom distress [Edmonton symptom assessment scale (ESAS)] and caregiver outcomes [Zarit Burden Interview {ZBI}, Hospital Anxiety and Depression scale(HADS) and FAMCARE] at week 12 in advanced lung cancer (ALC) patients receiving early palliative care consultation versus those who don't. II. Identify the cellular, molecular, and immune basis for the development of symptoms in patients with ALC.


Inclusion Criteria: 1. Have a diagnoses of advanced NSCLC (defined as locally advanced or metastatic) 2. Have no clinical evidence of cognitive failure, as evidenced by a Memorial Delirium Assessment Score of less than or equal to 7 of 30 at the time of consent. 3. Be at least 18 years of age. 4. Be able to understand the description of the project and give written informed consent. 5. Plan to receive their cancer treatment at MD Anderson Cancer Center. 6. Individuals with advanced cancer who are able to identify a primary caregiver who also agrees to participate (in person or by telephone) in the study. A caregiver will be defined as a spouse, first degree relative, or other person designated by the patient as providing direct assistance to the patient in his/her activities of daily living. Exclusion Criteria: 1. Patients to be excluded from the study will be those unable to complete the baseline assessment forms or to understand the recommendations for participation in this project. 2. Patients seen at the Thoracic center at UT MD Anderson Cancer Center after 8 weeks of the initial diagnosis (first cohort only - patients using the current Palliative Care referral practices prior to the implementation of the early palliative care program).



Primary Contact:

Study Chair
Siriam Yennu, MD
M.D. Anderson Cancer Center

Sriram Yennu, MD
Phone: 713-792-6085

Backup Contact:


Location Contact:

Houston, Texas 77030
United States

There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.